Weight loss with Ozempic or Wegovy can come with nausea, but avoiding certain foods and drinks can help patients manage the ...

Already established as cornerstone therapies in diabetes and obesity, GLP-1 receptor agonists have now cracked into the ...

The study recently published in the JAMA Health Forum looked at 16.7 million adults from 2013-2023 between 25-75 years old.

Suddenly the hottest thing in biopharma isn’t a new indication, disease target or modality—it’s manufacturing, and all of ...

Despite their remarkable efficacy for many populations, GLP-1s have a relatively low persistence rate over time, due to a ...

Nathan Nipper was named president and CEO of Boone, N.C.-based UNC Health Appalachian. Mr. Nipper has served as COO of the health system since 2022. He will succeed Chuck Mantooth, who announced in ...

Belichick is never going to be Mack Brown in a press conference - affable, friendly, kind, a pure gentleman - but he cracked ...

A huge Air Jordan and Nike restock is coming. Le Coq Sportif debuts the new R900 runner in the "Monochrome" pack. The entire ...

With the Biden administration pushing for Medicare, Medicaid coverage of GLP-1s, analysts disagree on whether it will decrease obesity costs.

The elusive chanteuse has 19 No. 1 hits to her credit, but watching them continue to achieve remarkable feats is something ...

Joe Breen, 38, is one of thousands of people whose experiences with GLP-1s such as Ozempic and Wegovy have radically changed their relationship with alcohol. Are these drugs the future for treating ...